• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Kaenon taps European partner


Kaenon Polarized announced a distribution partnership with optical manufacturer Rodenstock of Munich, Germany.

Newport Beach, CA-Kaenon Polarized announced a distribution partnership with optical manufacturer Rodenstock, of Munich, Germany.

Rodenstock will be the distribution partner of Kaenon Polarized products in the European Union, with an initial focus on Germany and Italy in 2010. Knitoptic Sarl will continue to operate as Kaenon's exclusive distribution partner in Switzerland.

"After 8 years of focused domestic distribution, this new distribution partnership . . . will allow both companies to leverage each other's success and strengths for the greater benefit of both," said Darren Rosenberg, chief operating officer and co-founder, Kaenon.

All of Kaenon's styles will continue to be available for prescription in Europe, featuring the benefits of the brand's polarized lenses (SR-91). Prescription sunglasses will be available in Kaenon's individually customized digitally surfaced Freestyle (Freeform) technology in both single vision and Freestyle progressive lenses.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.